Medizinonline Medizinonline
  • News
    • News
    • Market & Medicine
  • Patients
    • Disease patterns
    • Diagnostics
    • Therapy
  • Partner Content
    • Dermatology
      • Atopic dermatitis and psoriasis news
      • Dermatology News
    • Diabetes
      • Dia-Month Club – Type 2 Diabetes
      • Diabetes in Motion
      • Diabetes Podcasts
    • Gastroenterology
      • IBD matters
      • Forum Gastroenterology
      • Ozanimod: ulcerative colitis
      • Reflux Update
    • Immunology
      • Primary immunodeficiency – exchange of experience
    • Vaccinate
      • Herpes zoster
    • Infektiologie
    • Neurology
      • EXPERT ULTRASONIC: Introduction to ultrasound-guided injection
      • MS News
      • MS Therapy in Transition
    • Oncology
      • Swiss Oncology in motion
    • Orthopedics
      • Osteoporosis in motion
    • Phytotherapie
    • Practice Management
      • Aargau Cantonal Bank
      • Claraspital
    • Psychiatry
      • Geriatric Psychiatry
    • Rheumatology
  • Departments
    • Allergology and clinical immunology
    • General Internal Medicine
    • Anesthesiology
    • Angiology
    • Surgery
    • Dermatology and venereology
    • Endocrinology and Diabetology
    • Nutrition
    • Gastroenterology and Hepatology
    • Genetics
    • Geriatrics
    • Gynecology
    • Hematology
    • Infectiology
    • Cardiology
    • Nephrology
    • Neurology
    • Emergency and intensive care medicine
    • Nuclear Medicine
    • Oncology
    • Ophthalmology
    • ORL
    • Orthopedics
    • Pediatrics
    • Pharmacology and toxicology
    • Pharmaceutical medicine
    • Phlebology
    • Physical medicine and rehabilitation
    • Pneumology
    • Prevention and health care
    • Psychiatry and psychotherapy
    • Radiology
    • Forensic Medicine
    • Rheumatology
    • Sports Medicine
    • Traumatology and trauma surgery
    • Tropical and travel medicine
    • Urology
    • Dentistry
  • CME & Congresses
    • CME continuing education
    • Congress Reports
    • Congress calendar
  • Practice
    • Noctimed
    • Practice Management
    • Jobs
    • Interviews
  • Log In
  • Register
  • My account
  • Contact
  • English
    • Deutsch
    • Français
    • Italiano
    • Português
    • Español
  • Publications
  • Contact
  • Deutsch
  • English
  • Français
  • Italiano
  • Português
  • Español
Subscribe
Medizinonline Medizinonline
Medizinonline Medizinonline
  • News
    • News
    • Market & Medicine
  • Patienten
    • Krankheitsbilder
    • Diagnostik
    • Therapie
  • Partner Content
    • Dermatology
      • Atopic dermatitis and psoriasis news
      • Dermatology News
    • Diabetes
      • Dia-Month Club – Type 2 Diabetes
      • Diabetes in Motion
      • Diabetes Podcasts
    • Gastroenterology
      • IBD matters
      • Forum Gastroenterology
      • Ozanimod: ulcerative colitis
      • Reflux Update
    • Immunology
      • Primary immunodeficiency – exchange of experience
    • Vaccinate
      • Herpes zoster
    • Infektiologie
    • Neurology
      • EXPERT ULTRASONIC: Introduction to ultrasound-guided injection
      • MS News
      • MS Therapy in Transition
    • Oncology
      • Swiss Oncology in motion
    • Orthopedics
      • Osteoporosis in motion
    • Phytotherapie
    • Practice Management
      • Aargau Cantonal Bank
      • Claraspital
    • Psychiatry
      • Geriatric Psychiatry
    • Rheumatology
  • Departments
    • Fachbereiche 1-13
      • Allergology and clinical immunology
      • General Internal Medicine
      • Anesthesiology
      • Angiology
      • Surgery
      • Dermatology and venereology
      • Endocrinology and Diabetology
      • Nutrition
      • Gastroenterology and Hepatology
      • Genetics
      • Geriatrics
      • Gynecology
      • Hematology
    • Fachbereiche 14-26
      • Infectiology
      • Cardiology
      • Nephrology
      • Neurology
      • Emergency and intensive care medicine
      • Nuclear Medicine
      • Oncology
      • Ophthalmology
      • ORL
      • Orthopedics
      • Pediatrics
      • Pharmacology and toxicology
      • Pharmaceutical medicine
    • Fachbereiche 26-38
      • Phlebology
      • Physical medicine and rehabilitation
      • Phytotherapy
      • Pneumology
      • Prevention and health care
      • Psychiatry and psychotherapy
      • Radiology
      • Forensic Medicine
      • Rheumatology
      • Sports Medicine
      • Traumatology and trauma surgery
      • Tropical and travel medicine
      • Urology
      • Dentistry
  • CME & Congresses
    • CME continuing education
    • Congress Reports
    • Congress calendar
  • Practice
    • Noctimed
    • Practice Management
    • Jobs
    • Interviews
Login

Sie haben noch keinen Account? Registrieren

  • Lennox-Gastaut syndrome

Unmet need with a significant burden of disease

    • Education
    • Market & Medicine
    • Neurology
    • RX
    • Studies
  • 3 minute read

New data presented at the 15th European Epilepsy Congress show long delays in the diagnosis of Lennox-Gastaut syndrome (LGS) in Europe and a significant burden of disease due to seizure and non-seizure related impairments. New treatment options are therefore needed to improve the long-term prognosis of people with LGS.

The need for faster and more accurate diagnosis of Lennox-Gastaut syndrome (LGS) has been highlighted in a European real world study based on data from the Adelphi LGS Disease Specific Program (DSP)™. The data from 454 pediatric and adult LGS patients from across Europe shows that it takes an average of 12.3 months for a correct LGS diagnosis to be made after the first seizure occurs at an average age of 4 years. This clearly shows how long patients and their families in Europe have to wait for a correct diagnosis [1]. Despite patients receiving an average of more than three anti-seizure medications per day, challenges remain in the effective treatment of LGS: 71% of patients surveyed had at least one co-existing condition, with psychomotor or cognitive impairment, attention deficit hyperactivity disorder (ADHD), sleep disturbance or insomnia most commonly reported. 19% and 28% of those affected suffered from severe or very severe physical or mental impairments, many of which persisted with increasing age. 47% of patients reported having at least a slightly poorer quality of life and 39% reported that daytime seizures had the greatest impact on their quality of life. These findings underscore the need for new treatments that target both drug-resistant seizures and the non-seizure symptoms of LGS.

LGS affects approximately one million people worldwide [2], but diagnosis remains complex and challenging due to the lack of specific biomarkers for the disease, multiple possible causes and variable symptoms [3]. Although several approved drugs are available for LGS, there is still an unmet need for treatment. These medications provide improvement but generally do not have a sustained long-term effect [4].

Diagnostic support for medical professionals

Details of a new electronic decision support tool for LGS, based on the International League against Epilepsy (ILAE) diagnostic criteria, were also presented. Developed by ten epilepsy experts, the tool, whose digitization was funded by UCB (with no influence on the content), is designed to help physicians assess the likelihood that their patients have LGS. The questionnaire takes into account the mandatory, warning and exclusion features of LGS and provides a result that can be a guide for future treatments [5,6].The prototype is now being tested and validated before it can be used by healthcare professionals in the clinical setting.

Source: UCB

Literature:

  1. Strzelczyk A, et al: Insights into Lennox-Gastaut syndrome: A European real-world study on patient profiles and unmet needs. Poster presented at: The15th European Epilepsy Congress (EEC); 2024, September 7-11; Rome, Italy.
  2. www.lgsfoundation.org/wp-content/uploads/2024/05/Updated-MAY-2024.png. Last accessed: August 2024.
  3. Bourgeois BFD, Douglass LM, Sankar R. Epilepsia. 2014;55(Suppl. 4): 4-9.
  4. Auvin S. Revue Neurologique. 2020; 176: 444-447.
  5. Arzimanoglou A, Specchio N, Auvin S, et al: Development of an Electronic Diagnostic Criteria Tool for Lennox-Gastaut Syndrome (LGS). Poster presented at: The15th European Epilepsy Congress (EEC); 2024, September 7-11; Rome, Italy.
  6. Specchio N, Wirrell EC, Scheffer IE, et al: Epilepsia. 2022; 63(6): 1398-1442.

InFo NEUROLOGY & PSYCHIATRY 2024; 22(5): 37

Publikation
  • InFo NEUROLOGIE & PSYCHIATRIE
Related Topics
  • Disease burden
  • Epilepsy
  • Lennox-Gastaut syndrome
Previous Article
  • Basics of patient education

Promotion of self-management

  • RX
  • CME continuing education
  • Dermatology and venereology
  • General Internal Medicine
  • Physical medicine and rehabilitation
  • Prevention and health care
View Post
Next Article
  • Medical oncology

A multidisciplinary approach to an innovative future

  • RX
  • Congress Reports
  • Genetics
  • Gynecology
  • Oncology
  • Studies
  • Urology
View Post
You May Also Like
View Post
  • 5 min
  • Vaccine-preventable respiratory diseases

RSV and pneumococci: recommendations for risk groups

    • Congress Reports
    • General Internal Medicine
    • Infectiology
    • Pediatrics
    • Pneumology
    • Prevention and health care
    • RX
    • Studies
View Post
  • 5 min
  • Circadian rhythm in asthma

Chronotherapy can improve control

    • Allergology and clinical immunology
    • General Internal Medicine
    • Pneumology
    • RX
    • Studies
View Post
  • 6 min
  • Update on diagnostics, risk stratification and therapy

Acute myeloid leukemia 2025

    • Education
    • Hematology
    • Oncology
    • RX
    • Studies
View Post
  • 4 min
  • New practice guideline for fibromyalgia syndrome

Good times, bad times

    • Congress Reports
    • General Internal Medicine
    • Neurology
    • Pharmacology and toxicology
    • Physical medicine and rehabilitation
    • Rheumatology
    • RX
    • Sports Medicine
    • Studies
View Post
  • 5 min
  • Findings from the TRACK-FA study

Neuroimaging biomarkers in Friedreich’s ataxia

    • Genetics
    • Neurology
    • Pediatrics
    • RX
    • Studies
View Post
  • 12 min
  • Doing sport without fear or risk

Doing sport without fear or risk

    • CME continuing education
    • Endocrinology and Diabetology
    • Pediatrics
    • RX
    • Sports Medicine
View Post
  • 8 min
  • Chronic inducible urticaria

What has stayed the same, what has changed?

    • Allergology and clinical immunology
    • Congress Reports
    • Dermatology and venereology
    • RX
    • Studies
View Post
  • 4 min
  • National Health Report 2025

Mental health in Switzerland

    • General Internal Medicine
    • Practice Management
    • Prevention and health care
    • Psychiatry and psychotherapy
    • RX
    • Studies
Top Partner Content
  • Forum Gastroenterology

    Zum Thema
  • Herpes zoster

    Zum Thema
Top CME content
  • 1
    Doing sport without fear or risk
  • 2
    UV protection and skin cancer screening – Update 2025
  • 3
    Rare malignancy from a dermatological perspective
  • 4
    Yellow nail and Swyer-James syndrome
  • 5
    Diagnostic indications

Newsletter

Sign up and stay up to date

Subscribe
Medizinonline
  • Contact
  • General terms and conditions
  • Imprint

Input your search keywords and press Enter.